Skip to main content
SpringerLink
Log in

Loss of taste and smell during treatment with topiramate

  • Case Report
  • Published:
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity Aims and scope Submit manuscript

Abstract

Topiramate has already been suggested for treatment of olfactory hallucianation. This is a report of a three and a half-year-old boy with idiopathic generalized tonic colonic epilepsy. He had lost his ability to detect and recognize taste and odor during treatment with topiramate. Those abilities improved after discontinuation of topiramate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wu W.N., Heebner J.B., Streeter A.J., Moyer M.D., Takacs A.R., Doose R.D. Ferraiolo B.L.: Evaluation of the absorption, excretion, pharmacokinetics and metabolism of the anticonvulsant, topiramate in healthy men. Pharm. Res., 11, Suppl., S336, 1994.

    Google Scholar 

  2. Faught E., Wilder B.J., Ramsay R.E., Reife R.A., Kramer L.D., Pledger G.W.: Topiramate placebocontrolled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group. Neurology, 46, 1684–1690, 1996.

    CAS  Google Scholar 

  3. Langtry H.D., Gillis J.C., Davis R.: Topiramate — a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs, 54, 752–972, 1997.

    Article  CAS  PubMed  Google Scholar 

  4. Van Ameringen M., Mancini C., Pipe B., Campbell M., Oakman J.: Topiramate treatment for SSRI-induced weight gain in anxiety disorders. J. Clin. Psychiatry, 63, 981–984, 2002.

    Article  PubMed  Google Scholar 

  5. Dursun S.M., Devarajan S.: Clozapine weight gain, plus topiramate weight loss [letter]. Can. J. Psychiatry, 45, 198, 2000.

    CAS  PubMed  Google Scholar 

  6. Johnson J., Bourgeois J.A., Quanbeck C.: Treatment of olfactory hallucinations with topiramate. J. Clin. Psychopharmacol., 26, 340–341, 2006.

    Article  PubMed  Google Scholar 

  7. Anghelescu I., Klawe C., Himmerich H., Szegedi A.: Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction. J. Clin. Psychopharmacol., 21, 462–464, 2001.

    Article  CAS  PubMed  Google Scholar 

  8. Siniscalchi A., Gallelli L., Marigliano N.M., Orlando P., De Sarro G.: Use of topiramate for glossodynia. Pain Med., 8, 531–534, 2007.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center for Psychiatry and Behavioral Sciences, Shiraz University of Medical Sciences, Hafez Hospital, Shiraz, Iran

    A. Ghanizadeh

  2. The Academic Child Psychiatry Unit, Department of Paediatrics, Royal Children’s Hospital, The University of Melbourne, Melbourne, Australia

    A. Ghanizadeh

Authors
  1. A. Ghanizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Ghanizadeh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghanizadeh, A. Loss of taste and smell during treatment with topiramate. Eat Weight Disord 14, e137–e138 (2009). https://doi.org/10.1007/BF03327811

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03327811

Key words

Search

Navigation